LIMN Amends Bylaws: Quorum Reduced to 1/3 Voting Power, Seeks Stockholder Ratification at Annual Meeting
Liminatus Pharma, Inc. Class A Common Stock · Now $0.18
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS